Shenzhen FRD Science & Technology Co., Ltd. (SHE:300602)
China · Delayed Price · Currency is CNY 37.82
+0.46 (1.23%)
May 15, 2026, 3:09 PM CST
SHE:300602 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 6,989 | 6,527 | 4,867 | 4,245 | 4,032 | 2,992 |
Other Revenue | - | - | 163.63 | 100.68 | 92.25 | 65.87 |
| 6,989 | 6,527 | 5,031 | 4,346 | 4,125 | 3,058 | |
Revenue Growth (YoY) | 29.82% | 29.73% | 15.76% | 5.37% | 34.88% | 4.39% |
Cost of Revenue | 5,582 | 5,256 | 4,146 | 3,556 | 3,460 | 2,599 |
Gross Profit | 1,407 | 1,271 | 884.82 | 789.68 | 664.72 | 459.3 |
Selling, General & Admin | 453.69 | 428.02 | 385.83 | 416.81 | 409.12 | 330.77 |
Research & Development | 374.15 | 350.97 | 263.16 | 231.29 | 249.36 | 201.54 |
Other Operating Expenses | -27.8 | -26.12 | 9.68 | 0.49 | 24.89 | 15.7 |
Operating Expenses | 850.21 | 796.02 | 676.45 | 664.1 | 703.8 | 572.21 |
Operating Income | 557.25 | 474.86 | 208.37 | 125.59 | -39.08 | -112.9 |
Interest Expense | -34.91 | -31.74 | -34.79 | -55.73 | -61.67 | -37.66 |
Interest & Investment Income | 5.36 | 9.84 | 14.36 | 19.61 | 38.78 | 112.96 |
Currency Exchange Gain (Loss) | - | - | 19.88 | 3.3 | 44.22 | -10.47 |
Other Non Operating Income (Expenses) | -21.87 | -5.66 | -0.09 | -11.37 | -12.1 | -2.18 |
EBT Excluding Unusual Items | 505.83 | 447.3 | 207.72 | 81.39 | -29.86 | -50.26 |
Impairment of Goodwill | - | - | -4.28 | -2.69 | - | -61.63 |
Gain (Loss) on Sale of Investments | 0.13 | 0.14 | -30.32 | -13.4 | - | - |
Gain (Loss) on Sale of Assets | -28.47 | 2.6 | -1.48 | -0.84 | -0.15 | -3.63 |
Asset Writedown | -84.49 | -93.29 | -7.75 | -1.59 | - | -3.27 |
Other Unusual Items | - | - | 46.83 | 27.61 | 71.02 | 94.91 |
Pretax Income | 392.99 | 356.75 | 210.72 | 90.48 | 41.02 | -23.88 |
Income Tax Expense | 16.89 | -2.71 | 37.48 | 11.78 | -33.5 | 2.71 |
Earnings From Continuing Operations | 376.11 | 359.46 | 173.24 | 78.71 | 74.52 | -26.59 |
Minority Interest in Earnings | 8.05 | 5.1 | 15.65 | 24.51 | 21.67 | 56.68 |
Net Income | 384.15 | 364.56 | 188.89 | 103.21 | 96.19 | 30.09 |
Net Income to Common | 384.15 | 364.56 | 188.89 | 103.21 | 96.19 | 30.09 |
Net Income Growth | 50.93% | 93.00% | 83.01% | 7.31% | 219.62% | -85.59% |
Shares Outstanding (Basic) | 583 | 579 | 572 | 543 | 506 | 502 |
Shares Outstanding (Diluted) | 592 | 588 | 572 | 543 | 506 | 502 |
Shares Change (YoY) | 1.36% | 2.73% | 5.37% | 7.31% | 0.93% | 0.84% |
EPS (Basic) | 0.66 | 0.63 | 0.33 | 0.19 | 0.19 | 0.06 |
EPS (Diluted) | 0.65 | 0.62 | 0.33 | 0.19 | 0.19 | 0.06 |
EPS Growth | 48.89% | 87.88% | 73.68% | - | 216.67% | -85.71% |
Free Cash Flow | -109.2 | -127.81 | -16.45 | 111.71 | -626.36 | -647.31 |
Free Cash Flow Per Share | -0.18 | -0.22 | -0.03 | 0.21 | -1.24 | -1.29 |
Dividend Per Share | - | - | 0.038 | 0.033 | - | 0.010 |
Dividend Growth | - | - | 15.54% | - | - | -80.00% |
Gross Margin | 20.14% | 19.47% | 17.59% | 18.17% | 16.12% | 15.02% |
Operating Margin | 7.97% | 7.28% | 4.14% | 2.89% | -0.95% | -3.69% |
Profit Margin | 5.50% | 5.59% | 3.75% | 2.38% | 2.33% | 0.98% |
Free Cash Flow Margin | -1.56% | -1.96% | -0.33% | 2.57% | -15.19% | -21.17% |
EBITDA | 770.17 | 682.03 | 392.53 | 303.4 | 122.87 | 18.73 |
EBITDA Margin | 11.02% | 10.45% | 7.80% | 6.98% | 2.98% | 0.61% |
D&A For EBITDA | 212.92 | 207.17 | 184.16 | 177.81 | 161.95 | 131.64 |
EBIT | 557.25 | 474.86 | 208.37 | 125.59 | -39.08 | -112.9 |
EBIT Margin | 7.97% | 7.28% | 4.14% | 2.89% | -0.95% | -3.69% |
Effective Tax Rate | 4.30% | - | 17.79% | 13.02% | - | - |
Revenue as Reported | 6,989 | 6,527 | 5,031 | 4,346 | 4,125 | 3,058 |
Advertising Expenses | - | - | 5.1 | 3.21 | 3.16 | 2.2 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.